Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised …

SA Grupp, S Corbacioglu, HJ Kang… - The Lancet …, 2023 - thelancet.com
Background Sinusoidal obstruction syndrome, also known as veno-occlusive disease, is a
potentially life-threatening complication of haematopoietic stem-cell transplantation (HSCT) …

[HTML][HTML] Defibrotide for sinusoidal obstruction syndrome/veno-occlusive disease prophylaxis in high-risk adult patients: a single-center experience study

A Picod, A Bonnin, G Battipaglia, F Giannotti… - Biology of Blood and …, 2018 - Elsevier
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease
(VOD), is a serious complication after hematopoietic stem cell transplantation (HSCT) …

[PDF][PDF] Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation

M Park1ACDEF, HJ Park, HS Eom, YJ Kwon2B… - Ann …, 2013 - researchgate.net
Background: Sinusoidal obstruction syndrome (SOS) is a serious complication of
hematopoietic stem cell transplantation (HSCT), with a mortality rate of up to 90%. We report …

How I treat sinusoidal obstruction syndrome

N Chao - Blood, The Journal of the American Society of …, 2014 - ashpublications.org
Sinusoidal obstruction syndrome (SOS), previously called veno-occlusive disease (VOD)
can be a difficult problem after hematopoietic cell transplantation (HCT). The overall …

Sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic stem cell transplant: insights and therapeutic advances

S Nassereddine, S Alsubait, I Tabbara - Anticancer Research, 2018 - ar.iiarjournals.org
Hepatic sinusoidal obstruction syndrome (SOS) is a rare fatal clinical entity seen following
hematopoietic stem cell transplant (HSCT). It is more commonly reported to occur following …

[HTML][HTML] Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an …

M Mohty, F Malard, M Abecasis, E Aerts… - Bone marrow …, 2020 - nature.com
Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a
potentially life-threatening complication that can develop after hematopoietic cell …

[HTML][HTML] Defibrotide shows efficacy in the prevention of sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective study

Y Chalandon, AC Mamez, F Giannotti… - … and Cellular Therapy, 2022 - Elsevier
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease
(VOD), is a well-known complication of allogeneic hematopoietic stem cell transplantation …

[HTML][HTML] Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

M Mohty, D Blaise, R Peffault de Latour… - Bone Marrow …, 2023 - nature.com
Veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a potentially life-
threatening complication of haematopoietic cell transplantation (HCT) conditioning. The …

Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a …

SA Hopps, EB Borders… - Journal of Oncology …, 2016 - journals.sagepub.com
Sinusoidal obstruction syndrome, a complication occurring early after hematopoietic stem
cell transplantation, is a concern for clinicians. There are no guidelines to direct clinicians on …

[HTML][HTML] Sinusoidal obstruction syndrome/Veno-occlusive disease after autologous or allogeneic hematopoietic stem cell transplantation in children: a retrospective …

M Faraci, A Bertaina, R Luksch, E Calore… - Biology of Blood and …, 2019 - Elsevier
Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), is a
potentially life-threatening complication that may develop after hematopoietic stem cell …